Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MiMedx Group, Inc (MDXG) vs Zevra Therapeutics, Inc. (ZVRA)

MiMedx Group, Inc and Zevra Therapeutics, Inc. are both Biotechnology companies. MiMedx Group, Inc and Zevra Therapeutics, Inc. are of similar size ($686.5M and $668.7M). Zevra Therapeutics, Inc. trades at the lower P/E: 11.6× against 117×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 119.4% against −2.36%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs 1.76%) and the lower return on invested capital (0.00% vs 5.62%). Across the 21 metrics below, Zevra Therapeutics, Inc. leads on 14 and MiMedx Group, Inc on 7.

Valuation

Metric MDXG ZVRA Biotechnology median
P/E 116.75 11.62 7.88
P/S 1.94 4.80 11.47
P/B 3.20 3.00 2.52
Price to free cash flow 15.53 19.75 21.16
EV/EBITDA 28.01 6.59 0.74
EV/Sales 1.61 3.90 10.73
Earnings yield 0.86% 8.61% (28.84%)
Free cash flow yield 6.44% 5.06% (23.03%)

Profitability

Metric MDXG ZVRA Biotechnology median
Gross margin 78.85% 95.46% 65.16%
Operating margin 2.46% 60.54% 0.00%
Net margin 1.76% 42.25% 0.00%
Free cash flow margin 12.51% 24.30% 0.00%
Return on equity 2.88% 34.33% (57.72%)
Return on assets 2.18% 20.57% (49.22%)
Return on invested capital 5.62% 0.00% 0.00%

Growth

Metric MDXG ZVRA Biotechnology median
Revenue growth (TTM) (2.36%) 119.40% 5.64%
EPS growth (last fiscal year) 14.29% 159.21% —
Revenue growth, 5-year CAGR 11.02% 51.62% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXG ZVRA Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 5.33 5.17 4.73
Net debt to EBITDA (1.88) 39.03 0.96

Dividend

Metric MDXG ZVRA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MDXG ZVRA Biotechnology median
Market cap 686.53m 668.66m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack